Cargando…
Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.
Tamoxifen has been implicated as a risk factor for venous thrombosis in advanced breast cancer although the evidence for increased arterial or venous thrombosis with tamoxifen in early breast cancer is less clear. The effect of tamoxifen on haemostasis, and thereby possible thromboembolic risk, was...
Autores principales: | Jones, A. L., Powles, T. J., Treleaven, J. G., Burman, J. F., Nicolson, M. C., Chung, H. I., Ashley, S. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977438/ https://www.ncbi.nlm.nih.gov/pubmed/1419616 |
Ejemplares similares
-
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma
por: Saso, R, et al.
Publicado: (2000) -
Haemostatic Changes in Five Patients Infected with Ebola Virus
por: Smither, Sophie J., et al.
Publicado: (2019) -
Hæmostatic Agents
Publicado: (1856) -
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
por: Wang, Julie, et al.
Publicado: (2022) -
The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
por: Powles, T. J., et al.
Publicado: (1998)